MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • Oncolytics Biotech, Inc. (ONCY) Enters Into Agreement With NCIC CTG For Phase II Study Examining Treatment Of Colorectal Cancer 0 comments
    May 4, 2012 3:10 PM | about stocks: F

    Oncolytics Biotech, a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, announced today that it has reached an agreement with the NCIC Clinical Trials Group (NASDAQ:CTG) at Queen's University in Kingston, Ontario, under which the NCIC CTG will fund and perform a Phase II study of the effectiveness of REOLYSIN® in patients with advanced or metastatic colorectal cancer.

    "We are pleased to be conducting a second randomized study with the NCIC CTG," said Dr. Brad Thompson, President and CEO of Oncolytics. "This study will build on both our early preclinical and clinical colorectal cancer work, as well as preclinical research combining REOLYSIN with Avastin®. As a Company, we intend to continue expanding our clinical program to include randomized studies of frequently diagnosed cancers."

    The Phase II open-label, randomized, non-blinded, clinical study will be examining the difference in effectiveness between REOLYSIN when given in combination with FOLFOX-6 plus bevacizumab (Avastin) and the effectiveness of FOLFOX-6 plus bevacizumab alone. Approximately 50 response evaluable patients will be enrolled in each arm, after a six to nine patient safety run in.

    For further information about Oncolytics, please visit: www.oncolyticsbiotech.com

    Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

    Stocks: F
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.